{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670318741531392.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/sj.clpt.1996.43"}}],"dc:title":[{"@value":"Impairment of Drug Biotransformation in Renal Disease: An In Vitro Model"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670318741531396","@type":"Researcher","foaf:name":[{"@value":"A.M. Taburet"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318741531394","@type":"Researcher","foaf:name":[{"@value":"I. Vincent"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318741531395","@type":"Researcher","foaf:name":[{"@value":"L. Perello"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318741531392","@type":"Researcher","foaf:name":[{"@value":"B. Coret"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318741531393","@type":"Researcher","foaf:name":[{"@value":"B. Baune"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318741531397","@type":"Researcher","foaf:name":[{"@value":"V. Furlan"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00099236"},{"@type":"EISSN","@value":"15326535"}],"prism:publicationName":[{"@value":"Clinical Pharmacology & Therapeutics"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"1996-02","prism:volume":"59","prism:number":"2","prism:startingPage":"136","prism:endingPage":"136"},"reviewed":"false","createdAt":"2008-03-06","modifiedAt":"2023-11-07","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282680154785152","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effect of Hemodialysis on Hepatic Cytochrome P450 Functional Expression"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/sj.clpt.1996.43"},{"@type":"CROSSREF","@value":"10.1254/jphs.08042fp_references_DOI_8eDVSfwBkUhinHtaoydhCZXMaRb"}]}